Document Detail


A role of myocardial stiffness in cell-based cardiac repair: a hypothesis.
MedLine Citation:
PMID:  19243474     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Determining which time point is optimal for bone marrow-derived cell (BMC) transplantation for acute myocardial infarction (AMI) has attracted a great deal of attention. Studies have verified the interaction between cell treatment effect and transfer timing and have suggested that the optimal time frame for BMC therapy is day 4 to day 7 after AMI. However, the potential mechanism underlying the time-dependent therapeutic response remains unclear. Recently, a growing body of in vitro evidence has suggested that stem cells are able to feel and respond to the stiffness of their microenvironment to commit to a relevant lineage, indicating that soft matrices that mimic brain are neurogenic, stiffer matrices that mimic muscle are myogenic and comparatively rigid matrices that mimic collagenous bone prove osteogenic. Simultaneously, considering the fact that the myocardium post-infarction experiences a time-dependent stiffness change from flexible to rigid as a result of myocardial remodelling following tissue necrosis and massive extracellular matrix deposition, we presume that the myocardial stiffness within a certain time frame (possibly day 4-7) post-AMI might provide a more favourable physical microenvironment for the phenotypic plasticity and functional specification of engrafted BMCs committed to some cell lineages, such as endothelial cells, vascular smooth muscle cells or cardiomyocytes. The beneficial effect facilitates angiogenesis and myocardiogenesis in the infarcted heart, and subsequently leads to more amelioration of cardiac functions. If the present hypothesis were true, it would be of great help to understand the mechanism underlying the optimal timing for BMC transplantation and to establish a direction for the time selection of cell therapy.
Authors:
Shuning Zhang; Aijun Sun; Yanyan Liang; Qinyi Chen; Chunyu Zhang; Keqiang Wang; Yunzeng Zou; Junbo Ge
Related Documents :
18724034 - Delivery route in bone marrow cell transplantation should be optimized according to the...
15385154 - Cellular recruitment and the development of the myocardium.
9279664 - Stereological estimates of nuclear number in human ventricular cardiomyocytes before an...
16581974 - Evidence supporting paracrine hypothesis for akt-modified mesenchymal stem cell-mediate...
16636174 - Physiological and clinical consequences of relief of right ventricular outflow tract ob...
12422134 - Aldosterone: cardiovascular assault.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-02-20
Journal Detail:
Title:  Journal of cellular and molecular medicine     Volume:  13     ISSN:  1582-4934     ISO Abbreviation:  J. Cell. Mol. Med.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-05-14     Completed Date:  2009-07-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101083777     Medline TA:  J Cell Mol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  660-3     Citation Subset:  IM    
Affiliation:
Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Marrow Transplantation
Humans
Models, Cardiovascular*
Myocardial Infarction / therapy
Myocardium / pathology*
Time Factors
Wound Healing*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl ana...
Next Document:  Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK dependent PPARgamma expression an...